Gayle B. Ryan

Clinical Trial Results of a HER2/<i>neu</i> (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients

George E. Peoples, Jennifer M. Gurney, Mike M. Woll et al. · Journal of Clinical Oncology · 2005 · 214 citations

Medicine, Immunology, Oncology +17

Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients

Jennifer M. Gurney, Matthew T. Hueman, Michael Woll et al. · Journal of Clinical Oncology · 2005 · 183 citations

Medicine, Immunology, Oncology +17

Combined Clinical Trial Results of a HER2/<i>neu</i>(E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

George E. Peoples, Jarrod P. Holmes, Matthew T. Hueman et al. · Clinical Cancer Research · 2008 · 182 citations

Medicine, Immunology, Oncology +17

Phase I Clinical Trial of a HER-2/<i>neu</i> Peptide (E75) Vaccine for the Prevention of Prostate-Specific Antigen Recurrence in High-Risk Prostate Cancer Patients

Matthew T. Hueman, Zia A. Dehqanzada, Thomas E. Novak et al. · Clinical Cancer Research · 2005 · 53 citations

Medicine, Immunology, Oncology +17

Direct Measurement of Peptide-Specific CD8+ T Cells Using HLA-A2:Ig Dimer for Monitoring the In Vivo Immune Response to a HER2/neu Vaccine in Breast and Prostate Cancer Patients

Michael Woll, Christine M. Fisher, Gayle B. Ryan et al. · Journal of Clinical Immunology · 2004 · 37 citations

Life Sciences, Immunology, Oncology +17